Ken Fisher Biomarin Pharmaceutical Inc Transaction History
Fisher Asset Management, LLC
- $243 Billion
- Q3 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 13,546 shares of BMRN stock, worth $886,585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,546
Previous 13,424
0.91%
Holding current value
$886,585
Previous $1.11 Million
13.85%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.49 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.26 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.23 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$910 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$687 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...